Pages that link to "Q66886088"
Jump to navigation
Jump to search
The following pages link to Antibody Responses and Reactogenicity of Graded Doses of Inactivated Influenza A/New Jersey/76 Whole-Virus Vaccine in Humans (Q66886088):
Displayed 11 items.
- Confronting the avian influenza threat: vaccine development for a potential pandemic. (Q30342476) (← links)
- From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. (Q30342973) (← links)
- Refining the approach to vaccines against influenza A viruses with pandemic potential. (Q30381595) (← links)
- A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection (Q36249751) (← links)
- Responses of volunteers to inactivated influenza virus vaccines (Q36257974) (← links)
- Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients (Q37071008) (← links)
- A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults (Q37145744) (← links)
- A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. (Q37146354) (← links)
- Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs (Q45635728) (← links)
- Use of the enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study (Q45801487) (← links)
- Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions (Q45891068) (← links)